230 related articles for article (PubMed ID: 28741087)
41. Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus.
van den Berg L; Nossent H; Rekvig O
Clin Rheumatol; 2006 May; 25(3):347-52. PubMed ID: 16328091
[TBL] [Abstract][Full Text] [Related]
42. Performance analysis of automated evaluation of Crithidia luciliae-based indirect immunofluorescence tests in a routine setting - strengths and weaknesses.
Hormann W; Hahn M; Gerlach S; Hochstrate N; Affeldt K; Giesen J; Fechner K; Damoiseaux JGMC
Clin Chem Lab Med; 2017 Nov; 56(1):86-93. PubMed ID: 28672732
[TBL] [Abstract][Full Text] [Related]
43. Autoantibodies against dsDNA measured with nonradioactive Farr assay-an alternative for routine laboratories.
Lakota K; Švec T; Kveder T; Sodin-Šemrl S; Žigon P; Ambrožič A; Ogrič M; Markez S; Božič B; Tomšič M; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):353-359. PubMed ID: 30203316
[TBL] [Abstract][Full Text] [Related]
44. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
45. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
Rose T; Grützkau A; Hirseland H; Huscher D; Dähnrich C; Dzionek A; Ozimkowski T; Schlumberger W; Enghard P; Radbruch A; Riemekasten G; Burmester GR; Hiepe F; Biesen R
Ann Rheum Dis; 2013 Oct; 72(10):1639-45. PubMed ID: 23117242
[TBL] [Abstract][Full Text] [Related]
46. Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus.
Ekblom-Kullberg S; Kautiainen H; Alha P; Leirisalo-Repo M; Miettinen A; Julkunen H
Rheumatol Int; 2014 Mar; 34(3):341-5. PubMed ID: 24170320
[TBL] [Abstract][Full Text] [Related]
47. A fluorescence sedimentation assay for dsDNA antibodies.
Duus K; Draborg AH; Güven E; Moreno YM; Jacobsen S; Nielsen CT; Houen G
Scand J Clin Lab Invest; 2017 Oct; 77(6):465-471. PubMed ID: 28678535
[TBL] [Abstract][Full Text] [Related]
48. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
Jaekell HP; Trabandt A; Grobe N; Werle E
Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of a new automated enzyme fluoroimmunoassay using recombinant plasmid dsDNA for the detection of anti-dsDNA antibodies in SLE.
Villalta D; Bizzaro N; Corazza D; Tozzoli R; Tonutti E
J Clin Lab Anal; 2002; 16(5):227-32. PubMed ID: 12357451
[TBL] [Abstract][Full Text] [Related]
50. Rapid detection of autoantibodies to dsDNA with the particle gel immunoassay (ID-PaGIA).
Seltsam A; Schwind P; Abraham K; Hiepe F; Cygan S; Aebischer I; Salama A
Ann Rheum Dis; 2002 Apr; 61(4):367-9. PubMed ID: 11874846
[TBL] [Abstract][Full Text] [Related]
51. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
Massardo L; Martínez ME; Pérez R; Ramírez V; Foradori A; González A; Radrigán F; Gutiérrez F; Jacobelli S
Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606
[TBL] [Abstract][Full Text] [Related]
52. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
53. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
54. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
[TBL] [Abstract][Full Text] [Related]
55. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
Sjoholm AG; Martensson U; Sturfelt G
J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
[TBL] [Abstract][Full Text] [Related]
56. Myth and reality: practical test system for the measurement of anti-DNA antibodies in the diagnosis of systemic lupus erythematosus (SLE).
McCloskey LJ; Christner P; Jacobs-Kosmin D; Jaskowski TD; Hill HR; Lakos G; Teodorescu M
J Clin Lab Anal; 2010; 24(2):77-84. PubMed ID: 20333761
[TBL] [Abstract][Full Text] [Related]
57. Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection.
Almeida González D; Roces Varela A; Marcelino Rodríguez I; González Vera A; Delgado Sánchez M; Aznar Esquivel A; Casañas Rodríguez C; Cabrera de León A
J Immunol Methods; 2015 Dec; 427():30-5. PubMed ID: 26407840
[TBL] [Abstract][Full Text] [Related]
58. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
Burdash NM; Teti G; Papadopoulos V
Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
[TBL] [Abstract][Full Text] [Related]
59. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.
Flechsig A; Rose T; Barkhudarova F; Strauss R; Klotsche J; Dähnrich C; Schlumberger W; Enghard P; Burmester GR; Hiepe F; Biesen R
Clin Exp Rheumatol; 2017; 35(4):598-606. PubMed ID: 28281463
[TBL] [Abstract][Full Text] [Related]
60. Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus.
Yuan W; Cao H; Wan P; Shi R; Zhou S; Zheng J
Lupus; 2019 Oct; 28(12):1387-1396. PubMed ID: 31570052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
